146 related articles for article (PubMed ID: 30946857)
1. Arsenic trioxide blocked proliferation and cardiomyocyte differentiation of human induced pluripotent stem cells: Implication in cardiac developmental toxicity.
Bao Z; Han Z; Zhang B; Yu Y; Xu Z; Ma W; Ding F; Zhang L; Yu M; Liu S; Jin M; Yan G; Huang Q; Wang X; Hua B; Yang F; Li Y; Liu Y; Zagidullin N; Carvalho K; Li B; Wang N; Cai B
Toxicol Lett; 2019 Jul; 309():51-58. PubMed ID: 30946857
[TBL] [Abstract][Full Text] [Related]
2. Low-Dose Arsenic Trioxide Modulates the Differentiation of Mouse Embryonic Stem Cells.
Yuan W; Chen J; Huang H; Cai Z; Ling Q; Huang F; Huang Z
Chem Res Toxicol; 2018 Jun; 31(6):472-481. PubMed ID: 29767511
[TBL] [Abstract][Full Text] [Related]
3. Stage-specific Effects of Bioactive Lipids on Human iPSC Cardiac Differentiation and Cardiomyocyte Proliferation.
Sharma A; Zhang Y; Buikema JW; Serpooshan V; Chirikian O; Kosaric N; Churko JM; Dzilic E; Shieh A; Burridge PW; Wu JC; Wu SM
Sci Rep; 2018 Apr; 8(1):6618. PubMed ID: 29700394
[TBL] [Abstract][Full Text] [Related]
4. Granulocyte colony-stimulating factor potentiates differentiation induction by all-trans retinoic acid and arsenic trioxide and enhances arsenic uptake in the acute promyelocytic leukemia cell line HT93A.
Iriyama N; Yuan B; Hatta Y; Horikoshi A; Yoshino Y; Toyoda H; Aizawa S; Takeuchi J
Oncol Rep; 2012 Nov; 28(5):1875-82. PubMed ID: 22940758
[TBL] [Abstract][Full Text] [Related]
5. EBIO Does Not Induce Cardiomyogenesis in Human Pluripotent Stem Cells but Modulates Cardiac Subtype Enrichment by Lineage-Selective Survival.
Jara-Avaca M; Kempf H; Rückert M; Robles-Diaz D; Franke A; de la Roche J; Fischer M; Malan D; Sasse P; Solodenko W; Dräger G; Kirschning A; Martin U; Zweigerdt R
Stem Cell Reports; 2017 Feb; 8(2):305-317. PubMed ID: 28089668
[TBL] [Abstract][Full Text] [Related]
6. Coordinated Proliferation and Differentiation of Human-Induced Pluripotent Stem Cell-Derived Cardiac Progenitor Cells Depend on Bone Morphogenetic Protein Signaling Regulation by GREMLIN 2.
Bylund JB; Trinh LT; Awgulewitsch CP; Paik DT; Jetter C; Jha R; Zhang J; Nolan K; Xu C; Thompson TB; Kamp TJ; Hatzopoulos AK
Stem Cells Dev; 2017 May; 26(9):678-693. PubMed ID: 28125926
[TBL] [Abstract][Full Text] [Related]
7. Rho-associated kinase inhibitors promote the cardiac differentiation of embryonic and induced pluripotent stem cells.
Cheng YT; Yeih DF; Liang SM; Chien CY; Yu YL; Ko BS; Jan YJ; Kuo CC; Sung LY; Shyue SK; Chen MF; Yet SF; Wu KK; Liou JY
Int J Cardiol; 2015 Dec; 201():441-8. PubMed ID: 26313863
[TBL] [Abstract][Full Text] [Related]
8. Genome-Wide Temporal Profiling of Transcriptome and Open Chromatin of Early Cardiomyocyte Differentiation Derived From hiPSCs and hESCs.
Liu Q; Jiang C; Xu J; Zhao MT; Van Bortle K; Cheng X; Wang G; Chang HY; Wu JC; Snyder MP
Circ Res; 2017 Aug; 121(4):376-391. PubMed ID: 28663367
[TBL] [Abstract][Full Text] [Related]
9. Characterization of cytotoxicity induced by arsenic trioxide (a potent anti-APL drug) in rat cardiac myocytes.
Raghu KG; Cherian OL
J Trace Elem Med Biol; 2009; 23(1):61-8. PubMed ID: 19203718
[TBL] [Abstract][Full Text] [Related]
10. Arsenic trioxide alters the differentiation of mouse embryonic stem cell into cardiomyocytes.
Rebuzzini P; Cebral E; Fassina L; Alberto Redi C; Zuccotti M; Garagna S
Sci Rep; 2015 Oct; 5():14993. PubMed ID: 26447599
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of Long Non-Coding RNA Kcnq1ot1: An Important Mechanism of Arsenic Trioxide-Induced Long QT Syndrome.
Jiang Y; Du W; Chu Q; Qin Y; Tuguzbaeva G; Wang H; Li A; Li G; Li Y; Chai L; Yue E; Sun X; Wang Z; Pavlov V; Yang B; Bai Y
Cell Physiol Biochem; 2018; 45(1):192-202. PubMed ID: 29339628
[TBL] [Abstract][Full Text] [Related]
12. Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide.
Jung YS; Cheong HJ; Kim SJ; Kim KH; Lee N; Park HS; Won JH
Leuk Res; 2014 Aug; 38(8):977-82. PubMed ID: 24953245
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of arsenic trioxide-mediated changes in human induced pluripotent stem cells (IPS).
Graham B; Stevens J; Wells P; Sims J; Rogers C; Leggett SS; Ekunwe S; Ndebele K
Int J Environ Res Public Health; 2014 Jul; 11(7):7524-36. PubMed ID: 25054231
[TBL] [Abstract][Full Text] [Related]
14. Ascorbic acid enhances the cardiac differentiation of induced pluripotent stem cells through promoting the proliferation of cardiac progenitor cells.
Cao N; Liu Z; Chen Z; Wang J; Chen T; Zhao X; Ma Y; Qin L; Kang J; Wei B; Wang L; Jin Y; Yang HT
Cell Res; 2012 Jan; 22(1):219-36. PubMed ID: 22143566
[TBL] [Abstract][Full Text] [Related]
15. Morphine Attenuated the Cytotoxicity Induced by Arsenic Trioxide in H9c2 Cardiomyocytes.
Amini-Khoei H; Hosseini MJ; Momeny M; Rahimi-Balaei M; Amiri S; Haj-Mirzaian A; Khedri M; Jahanabadi S; Mohammadi-Asl A; Mehr SE; Dehpour AR
Biol Trace Elem Res; 2016 Sep; 173(1):132-9. PubMed ID: 26815588
[TBL] [Abstract][Full Text] [Related]
16. Human Induced Pluripotent Stem Cell-Derived Cardiac Progenitor Cells in Phenotypic Screening: A Transforming Growth Factor-β Type 1 Receptor Kinase Inhibitor Induces Efficient Cardiac Differentiation.
Drowley L; Koonce C; Peel S; Jonebring A; Plowright AT; Kattman SJ; Andersson H; Anson B; Swanson BJ; Wang QD; Brolen G
Stem Cells Transl Med; 2016 Feb; 5(2):164-74. PubMed ID: 26683871
[TBL] [Abstract][Full Text] [Related]
17. A synthetic DNA-binding inhibitor of SOX2 guides human induced pluripotent stem cells to differentiate into mesoderm.
Taniguchi J; Pandian GN; Hidaka T; Hashiya K; Bando T; Kim KK; Sugiyama H
Nucleic Acids Res; 2017 Sep; 45(16):9219-9228. PubMed ID: 28934500
[TBL] [Abstract][Full Text] [Related]
18. Arsenic trioxide decreases the amount and inhibits the function of regulatory T cells, which may contribute to its efficacy in the treatment of acute promyelocytic leukemia.
Xu W; Li X; Quan L; Yao J; Mu G; Guo J; Wang Y
Leuk Lymphoma; 2018 Mar; 59(3):650-659. PubMed ID: 28679299
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of arsenic trioxide on retinoblastoma: cell differentiation and apoptosis depending on arsenic trioxide concentration.
Kim JH; Kim JH; Yu YS; Kim DH; Kim CJ; Kim KW
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1819-23. PubMed ID: 19060284
[TBL] [Abstract][Full Text] [Related]
20. The effect of simultaneous administration of arsenic trioxide and microvesicles derived from human bone marrow mesenchymal stem cells on cell proliferation and apoptosis of acute myeloid leukemia cell line.
Abbaszade Dibavar M; Soleimani M; Atashi A; Rassaei N; Amiri S
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S138-S146. PubMed ID: 30600718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
